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Aims. Visceral obesity is associated with an increased risk of cardiometabolic diseases and it is important to identify the underlying
mechanisms.There is growing evidence thatmitochondrial dysfunction is associatedwithmetabolic disturbances related to visceral
obesity. In addition, maintaining mitochondrial DNA (mtDNA) copy number is important for preserving mitochondrial function.
Therefore, we investigated the relationship betweenmtDNA copy number and visceral fat in healthy young adults.Methods. A total
of 94 healthy young subjects were studied. Biomarkers of metabolic risk factors were assessed along with body composition by
computed tomography. mtDNA copy number was measured in peripheral leukocytes using real-time polymerase chain reaction
(PCR) methods. Results. The mtDNA copy number correlated with BMI (𝑟 = −0.22, 𝑃 = 0.04), waist circumference (𝑟 = −0.23,
𝑃 = 0.03), visceral fat area (𝑟 = −0.28, 𝑃 = −0.01), HDL-cholesterol levels (𝑟 = 0.25, 𝑃 = 0.02), and hs-CRP (𝑟 = 0.32, 𝑃 =
0.02) after adjusting for age and sex. Both stepwise and nonstepwise multiple regression analyses confirmed that visceral fat area
was independently associated with mtDNA copy number (𝛽 = −0.33, 𝑃 < 0.01, 𝛽 = 0.32, and 𝑃 = 0.03, resp.). Conclusions.
An independent association between mtDNA content and visceral adiposity was identified. These data suggest that mtDNA copy
number is a potential predictive marker for metabolic disturbances. Further studies are required to understand the causality and
clinical significance of our findings.
1. Introduction
The prevalence of obesity is increasing worldwide. Obesity
is a well-known risk factor for numerous health problems,
including cardiovascular disease (CVD), diabetes melli-
tus (DM), and cancer [1, 2]. Recent data shows that the
regional distribution of body fat, rather than overall obesity,
contributes to disease processes [3]. Visceral fat is more
metabolically active than subcutaneous fat [4] and affects
the development ofmetabolic disturbances, including insulin
resistance [5] and dyslipidemia [6]. The precise role of
visceral adiposity in metabolic disturbance is still unknown
but proinflammatory cytokines and adipokines secreted by
visceral adipocytes are believed to be involved [7].
Mitochondria are organelles that play an important role
in the energy synthesis of the cells. Mitochondria synthe-
size the molecules essential for the body metabolism and
influence metabolic homeostasis of the entire body [8].
Mitochondrial function decreases with aging and mitochon-
drial dysfunction is related to various age-related conditions
including type 2 DM and CVD [9]. Mitochondria are highly
vulnerable to oxidative damage [10, 11] and mitochondrial
dysfunction induced by oxidative damage is considered to
contribute to the development of cardiometabolic diseases
[9].
Mitochondrial DNA copy number, which reflects the
content of mtDNA, is associated with mitochondrial gene
stability and mitochondrial biogenesis [12]. Mitochondrial
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dysfunction reduces the contents of mitochondria, which is
expressed as a decreased mtDNA copy number [12]. Fur-
thermore, reducedmitochondrial DNA content of peripheral
blood as well as specific organs was associated with the
development of IR, type 2 DM [13], cognitive function [14],
and metabolic syndrome [15]. Adipose tissue is the main
source of cytokines and adipokines that increase systemic
oxidative stress. Thus, obesity may decrease mitochondrial
function. Previous results show that human obesity is asso-
ciated with mitochondrial dysfunction. However, few studies
have investigated the quantitative changes in mitochondria
according to increased adiposity. The studies that have been
performed have yielded mixed results. Furthermore, the
potential differences in mitochondrial content according to
the regional distribution of adiposity were not fully evaluated.
Adipose tissue is the main source of cytokines and
adipokines that increase systemic oxidative stress [16].
Thus, obesity may decreasemitochondrial function. Previous
results show that human obesity is associated with mito-
chondrial dysfunction [17]. However, few studies have inves-
tigated the quantitative changes in mitochondria according
to increased adiposity. The studies that have been performed
have yielded mixed results [18, 19]. Furthermore, the poten-
tial differences in mitochondrial content according to the
regional distribution of adiposity were not fully evaluated.
Therefore, we investigated the association between
peripheral blood mtDNA copy number and visceral fat
accumulation among 94 healthy young-aged people.
2. Materials and Methods
2.1. Study Sample. This was a secondary data analysis from
the Yonsei Aging Cohort, which was designed to investigate
health-related markers among people of various ages [20].
Participants visited the Department of Family Medicine at
Severance Hospital for routine health checkups and not
for investigations or treatments of specific symptoms or
diseases. All subjects participated in the study voluntarily,
and written informed consent was obtained from each
participant. Questionnaires about lifestyles and underlying
medical conditions, overnight-fasting blood tests, and fat
measurements with computed tomography were performed
as baseline tests. Two additional samples of blood were
collected from participants who agreed to store their blood
samples for 10 years for future analysis. An additional separate
written informed consent was obtained from each participant
before performing the additional laboratory test with the
stored blood samples.
Because the aim of our study was to investigate the asso-
ciation between visceral obesity and mtDNA copy number
in healthy young participants, we selected 203 people aged
from 20 to 40 years. Mitochondrial DNA copy numbers
were measured with the stored blood samples. Thus we
excluded 75 participants who did not agree to store their
blood samples. Fifteen additional participants were excluded,
because data for their abdominal visceral fat areas were
missing. To select a healthy population, participants with
histories of hypertension, diabetes mellitus, coronary artery
occlusive disease, chronic liver disease, chronic renal disease,
or cancer were not included. Subjects who participated in
regular exercise were also excluded from the data analysis.
Regular exercise was defined as physical exercise or physical
work that was performed for more than 30 minutes, three
times perweek.We also excluded participantswhousedmed-
ications, including antihypertensive agents, lipid-reducing
drugs, oral hypoglycemic agents, and nutrient supplements,
which could affect cardiometabolic functions. Ninety-four
patients were included in our analyses. The study complied
with the Declaration of Helsinki, and the institutional review
board of Yonsei University College ofMedicine approved this
study.
2.2. Measurements. All participants were questioned about
lifestyle factors, including alcohol consumption and smoking.
Alcohol consumption was defined as drinking alcohol more
frequently than once per week. Smoking was defined as
current cigarette smoking.
Anthropometric measurements were made by a single
examiner. After a 10-minute resting period, blood pressure
was measured in the sitting position. Body mass index was
calculated as weight (kg) divided by height squared (cm2).
Abdominal fat tissue area was calculated using computed
tomography (Tomoscan 350; Philips, Mahwah, NJ, USA) as
described previously [21].
Blood samples were collected after at least an 8-hour
overnight fasting period. Fasting glucose, high sensitive
C-reactive protein (hs-CRP), total cholesterol, triglyceride,
and high-density lipoprotein (HDL) cholesterol levels were
measured using an ADVIA 1650 chemistry system (Siemens
Medical Solution, Tarrytown, NY, USA). Fasting insulin
levels were determined using electrochemiluminescence
immunoassays with an Elecsys 2010 (Roche, Indianapolis, IN,
USA). Insulin resistance was calculated using the homeosta-
sismodel assessment of insulin resistance (HOMA-IR) index:
(insulin [𝜇IU/mL] × fasting blood glucose [mg/dL]/18)/22.5.
2.3. Measurement of Mitochondrial DNA Copy Numbers in
Peripheral Blood. To reduce variations inmeasurements, one
examiner measured all parameters throughout the study.
mtDNA in peripheral leukocytes was extracted from 1mL of
whole blood using the QIAamp Tissue Kit 250 (Qiagen Inc.,
Valencia, CA, USA). The relative mtDNA copy number was
measured by a real-time polymerase chain reaction (QPCR)
and corrected by simultaneous measurement of the nuclear
DNA according to the method of Wong and Cortopassi [22]
and Liu et al. [11]. Reactions were performed using a Light
Cycler-Fast Start DNA Master SYBR Green I kit, purchased
from Roche Applied Science (Pleasanton, CA, USA). The
forward and reverse primers of 𝛽-globin (used to amplify a
268 bp product) were 5󸀠-GAAGAGCCAAGGACAGGTAC-
3󸀠 and 5󸀠-CAACTTCATCCACGTTCACC-3󸀠, respectively.
The forward and reverse primers of the mitochondrial gene
(ND1 gene) used to amplify a 153 bp product were 5󸀠-
AACATACCCATGGCCAACCT-3󸀠 and 5󸀠-AGCGAAGGG-
TTGTAGTAGCCC-3󸀠, respectively. After denaturation at
95∘C for 300 seconds, DNA samples were treated at 95∘C for
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0.1 seconds, 58∘C for 6 seconds, and 72∘C for 18 seconds for
40 cycles. A total of 20 ng of DNA was used and the number
of PCR cycles to reach this amount of DNA was defined as
the threshold cycle (Ct). The following equation was used
to quantify the mtDNA copy number relative to 𝛽-globin:
relative copy number = 2ΔCt (ΔCt = Ct
𝛽-globin − CtND1) [23].
The intra-assay and interassay coefficients of variation of Ct
values for the ND1 gene were 4.5% and 5.8%, respectively.
2.4. Statistical Analyses. Normally distributed data are ex-
pressed as the mean ± standard deviation (SD). Nonnor-
mally distributed data are expressed asmedian and interquar-
tile range. mtDNA, fasting insulin, HOMA-IR, total choles-
terol, triglyceride, and hs-CRP were log transformed to
improve the skewness of the distribution. Pearson correlation
analyses were performed to evaluate relationships between
mtDNA and other metabolic variables. Stepwise multiple
linear regression analysis was performed to identify factors
that contributed to mtDNA copy number. If there was a
significant correlation (𝑟 > 0.7) between two variables, only
one variable was selected and entered into the model to avoid
multicollinearity. In addition, nonstepwise multiple linear
regression analysis was performed. Variables with 𝑃 < 0.05
in the univariate analysis and clinically important variables,
including age, BMI, and HOMA-IR, were entered into the
nonstepwise analysis.
We performed all statistical analyses using the Statistical
Package for the Social Sciences, version 18.0 (SPSS Inc.,
Chicago, IL, USA). Statistical significance was defined as 𝑃 <
0.05.
3. Results
The clinical characteristics of the study subjects are shown
in Table 1. The mean age of the study subjects was 32.26 ±
9.14 years, and the median (25–75th percentile) mtDNA copy
number was 302.08 (48.98–891.25). After adjusting for age
and sex, mtDNA copy numbers positively correlated with
HDL-cholesterol levels (𝑟 = 0.25, 𝑃 = 0.02) and negatively
correlated with BMI (𝑟 = −0.22, 𝑃 = 0.04), waist circum-
ference (𝑟 = −0.23, 𝑃 = 0.03), visceral fat area (𝑟 = −0.28,
𝑃 = −0.01), and hs-CRP (𝑟 = 0.32, 𝑃 = 0.02) (Table 2).
The mean mtDNA level in the nonsmoking group (2.50 ±
0.81) was significantly higher than that of the smoking group
(1.80 ± 0.74, 𝑃 < 0.001). In addition, the mean mtDNA level
of female subjects (2.57 ± 0.80) was significantly higher than
that of male subjects (2.15 ± 0.83, 𝑃 = 0.02). There were no
significant differences in mean mtDNA levels between sub-
jects that consumed alcohol (2.17 ± 0.76) and subjects that
did not (2.42 ± 0.88, 𝑃 = 0.17). Figure 1 shows the different
relationships between mtDNA copy number and abdominal
adiposity according to the regional fat distribution. The
mtDNA copy numbers negatively correlated with visceral
fat area. However, there was no significant correlation with
subcutaneous fat.
In stepwise multiple linear regression analyses, visceral
fat area, hs-CRP, HDL-cholesterol, and smoking accounted
for 35% of the variance in mtDNA copy number. Thus,
Table 1: Clinical characteristics of study subjects (𝑛 = 94).
Variables Total (𝑛 = 94)
Age (years) 29.57 ± 0.95
mtDNA copy number# 302.08 (48.98–891.25)
Male (𝑛, %) 54 (57.4)
Adiposity index
BMI (kg/m2) 27.70 ± 4.36
Waist (cm) 93.06 ± 11.19
Visceral fat area (cm2) 95.22 ± 45.45
Subcutaneous fat area (cm2) 245.93 ± 100.14
Blood pressure (mmHg)
Systolic 125.21 ± 15.59
Diastolic 76.96 ± 12.87
Fasting glucose (mg/dL) 87.77 ± 11.40
Fasting insulin (𝜇IU/mL)# 7.51 (4.53–11.84)
HOMA-IR# 1.57 (0.97–2.68)
Lipid profile (mg/dL)
Total cholesterol# 181.00 (164.00–215.25)
Triglyceride# 89.00 (63.00–131.25)
HDL-cholesterol 52.25 ± 11.92
Hs-CRP# (mg/L) 0.46 (0.10–1.42)
Smoking (𝑛, %) 23 (24.5)
Alcohol consumption (𝑛, %) 34 (36.2)
Note: BMI: bodymass index; HOMA-IR: Homeostasis Model of Assessment
of Insulin Resistance; HDL: high-density lipoprotein; LDL: low-density
lipoprotein; hsCRP: high sensitive C reactive protein.
Alcohol consumption was defined as drinking alcohol more frequently than
once per week.
Normally distributed data are shown as the mean (±SD).
#Non-normally distributed data are presented asmedians (25–75 percentiles)
and analyzed after log-transformation to correct for skewed distribution.
these variables were considered to be explanatory variables
for mtDNA copy number. In addition, nonstepwise multiple
regression analyses indicated that visceral fat, smoking, and
hs-CRP levels were independently associated with mtDNA
copy numbers, as these variables accounted for 58% of the
variance (Table 3).
4. Discussion
Our cross-sectional study revealed a relationship between
peripheral blood mtDNA copy number and visceral obesity
in a healthy Korean young-aged population. This associa-
tion remained significant after adjusting for BMI and other
confounding factors. In addition, our study showed a sig-
nificant relationship between mtDNA copy number with
smoking, the components of metabolic syndrome (waist
circumference, blood pressure, and HDL-cholesterol), and
cardiovascular risk factors (systolic and diastolic BP), which
is consistent with the findings of previous studies [15, 24].
Themitochondrion is an organellewith diverse functions,
including energy synthesis, cellular remodeling, and regula-
tion of cell metabolism. Mitochondrial dysfunction induces
various metabolic diseases, including insulin resistance,
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Figure 1: The relationship between abdominal visceral fat area, abdominal subcutaneous fat area, and mtDNA copy numbers. Coefficients
(𝑟) and 𝑃 values were calculated using the Pearson correlation model.
Table 2: The correlation between mtDNA copy numbers# and
various parameters.
Variables Unadjusted Age, sex adjusted
𝑟 𝑃-value 𝑟 𝑃-value
Age (years) −0.28 0.01
Adiposity index −0.25 0.01 −0.22 0.04
BMI (kg/m2) −0.33 <0.01 −0.23 0.03
Waist (cm) −0.40 <0.01 −0.28 0.01
Visceral fat area (cm2)# −0.16 0.14 −0.21 0.09
Subcutaneous fat area (cm2)
Blood pressure (mmHg)
Systolic −0.22 0.04 −0.11 0.32
Diastolic −0.29 0.01 −0.15 0.17
Fasting glucose (mg/dL) 0.19 0.09 0.14 0.21
Fasting insulin (𝜇IU/mL)# −0.12 0.23 −0.17 0.12
HOMA-IR# −0.07 0.15 −0.12 0.27
Lipid profile (mg/dL)
Total cholesterol# −0.09 0.42 −0.03 0.80
Triglyceride# −0.37 <0.01 −0.18 0.09
HDL-cholesterol# 0.37 <0.01 0.25 0.02
Hs-CRP (mg/L) −0.42 <0.01 0.32 0.02
#Values analyzed after log-transformation to correct for skewed distribution.
Coefficients (𝑟) and 𝑃 values were calculated using the Pearson correlation
model.
type-2 diabetes mellitus, and CVD [9]. Multiple biochem-
ical mechanisms, including impaired fatty-acid oxidation,
and mitochondrial reactive oxygen stress, explain the link
between mitochondrial dysfunction and pathologic condi-
tions [25]. Although mitochondria are present in all types
of cells, increasing evidence indicates that mitochondrial
function in adipocytes is important for metabolic regulation.
In an experimental animal model, rats with visceral obesity
showed defective oxidative metabolism and reduced mito-
chondrial gene expression [26]. Kraunsøe et al. reported that
Table 3: Multiple regression analyses for mtDNA copy number#.
(a) Stepwise model
𝛽 coefficient SE 𝑃-value
Visceral fat area −0.33 0.00 <0.01
Hs-CRP (mg/L) −0.32 0.05 <0.01
Smoking# (%) −0.21 0.18 0.01
HDL-cholesterol (mg/dL) 0.21 0.39 0.04
𝑟
2
= 0.35. Variables included in the stepwise model for mtDNA were
age, sex, BMI, alcohol consumption, smoking, systolic BP, total cholesterol,
HDL-cholesterol, fasting glucose, HOMA-IR and visceral fat area.
To avoid multi-collinearlity, diastolic BP, triglycerides and subcutaneous fat
area were not included in the stepwise model.
#Values analyzed after log-transformation to correct for skewed distribu-
tion.
(b) Non-stepwise model
Variables 𝛽 coefficient SE 𝑃-value
Age (years) −0.05 0.02 0.30
Male (%) 0.03 0.20 0.89
BMI (kg/m2) −0.12 0.03 0.43
Smoking (%) −0.42 0.20 0.03
Systolic BP (mmHg) 0.00 0.01 0.69
Visceral fat area (cm2) −0.32 0.00 0.03
HDL-cholesterol (mg/dL) 0.21 0.42 0.07
Fasting glucose (mg/dL) −0.04 0.00 0.66
HOMA-IR −0.04 0.16 0.41
hs-CRP (mg/L) −0.19 0.06 0.02
𝑟
2
= 0.58. Variables included in the non-stepwise model for mtDNA
were age, sex, BMI, smoking, systolic BP, HDL-cholesterol, fasting glucose,
HOMA-IR and hs-CRP.
mitochondrial respirationwas reduced in the visceral adipose
tissues of obese humans compared to that in subcutaneous
fat tissues [27]. Furthermore, obese people have been shown
to have defective mitochondrial ATP formation compared
with that of nonobese people [28]. However, there are mixed
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results fromhuman clinical studies regarding the quantitative
aspects of mtDNA and regional distribution of adiposity.
Yin et al. reported a modest decrease in mtDNA content of
omental adipocytes from obese men compared with that of
nonobesemen [29]. In a Korean study, an inverse relationship
was reported between peripheral mitochondrial DNA copy
number and visceral fat mass [18]. However, some studies
showed no correlation between mtDNA copy number and
regional distribution of adiposity. One study showed no
correlation between mtDNA copy number and waist-hip
ratio which reflects visceral obesity [30]. Furthermore, results
that are opposite to those of our study have also been reported
[19, 31, 32]. The investigator of those studies suggested that
mtDNA content may increase secondary to mitochondrial
dysfunction. Therefore, the association between visceral
obesity and mtDNA copy number remains unclear. Our
study participants were apparently healthy, young subjects
from 20–40 years of age without chronic metabolic diseases.
Therefore, although we could not determine causality, our
results suggest that visceral fat accumulationmay affectmito-
chondrial DNA content in apparently healthy population
without metabolic disturbances.
The precise mechanism that explains the association
between mitochondrial DNA copy number and visceral
fat mass remains unknown. We could not find the causal
factor through our cross-sectional study. However, the results
suggest possible mechanisms.
First, increased chronic systemic inflammation according
to the secretion of proinflammatory cytokines and adipokines
may play important roles in the relationship. Visceral adi-
pose tissue is the main site of secretion of proinflamma-
tory cytokines, which induce mitochondrial dysfunction by
affecting signaling pathways associated with mitochondrial
biogenesis. Visceral adipose tissue is themain site of secretion
of proinflammatory cytokines, which induce mitochondrial
dysfunction by affecting signaling pathways associated with
mitochondrial biogenesis. For example, in cultured fat and
muscle tissue, TNF-𝛼 depleted endothelial nitric oxide syn-
thase expression along with mitochondrial biogenesis defects
and adipocytes with defective TNF-𝛼 signaling showed par-
tial recovery of mitochondrial function in obese mice [33]. In
our study, increased mtDNA copy number was significantly
associated with decreased hs-CRP level which reflects the
total inflammatory status of human body. Furthermore hs-
CRP level was also positively associated with visceral fat
accumulation after it was adjusted for age and sex (𝑟 = 0.5,
𝑃 < 0.05) (data not shown). Because both visceral adiposity
and mitochondrial DNA copy number were associated with
systemic inflammatory status, increased inflammation level
may explain the observed link between visceral obesity and
decreased mitochondrial contents. However, the association
between visceral fat accumulation and mitochondrial copy
number remained statistically significant after adjustment for
hs-CRP, suggesting that the association was, at least in part,
independent of systemic inflammation. Furthermore, it is
impossible to find out the specific roles of proinflammatory
cytokines and adipokines in the observed association in our
study.Therefore,measurement of proinflammatory cytokines
and adipokines should be performed in the future.
Second, free fatty acids that accumulated in the visceral
adipose tissue may affect the decreased mtDNA copy num-
ber. Increased levels of free fatty acids promote increased
synthesis of toxic fatty-acid-delivered metabolites. These
metabolites elevate the level of oxidative stress, driving
mitochondrial dysfunction [34]. Therefore increased free
fatty acids according to the visceral fat accumulation may
induce the decreased mitochondrial contents.
This study has several limitations. First, the cross-
sectional design of our study cannot determine a causal rela-
tionship between mtDNA copy number and visceral obesity
and the small sample size is another limitation of the current
study. Although the correlation was statistically significant,
the low power was another limitation. Therefore, we cannot
generalize the results to the population at large. In addition,
we did not perform fat biopsy, which is the gold standard for
investigation of mitochondrial function. However, it is easier
to obtain peripheral blood leukocytes than muscle tissue.
And decreased mtDNA copy number in peripheral blood
leukocytes correlated well with mitochondrial dysfunction in
skeletal muscle [35, 36]. Finally, this study did not measure
levels of proinflammatory cytokines and adipokines. There-
fore our study cannot directly investigate the role of cytokines
and adipokines as mediators between visceral adiposity and
reduced mitochondrial DNA copy number. We agree that
assessing inflammatory cytokine and adipokine levels will
provide additional important information in future studies.
In conclusion, our study shows that peripheral blood
mtDNA copy number is associated with abdominal visceral
fat area in 94 healthy young-aged subjects. Although the
causal direction of the relationship between mtDNA copy
number and visceral obesity cannot be determined, our study
collectively suggests that decreased mitochondrial contents
may be a mediator that links visceral obesity and metabolic
disturbances. Further studies are required to better under-
stand the pathophysiological and clinical significance of our
findings.
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